Mechanistically, SETD8 inhibits the transcriptional activity of RRAD by binding to the promoter region of RRAD, thus downregulating the expression of RRAD and resulting in a decrease in the incidence of ferroptosis in pancreatic cancer cells. Here, KMT5A is linked to familial pancreatic carcinoma.